From endothelial epigenetic switching to a vascular-readiness compass for cancer immunotherapy
Angiogenesis · 15.06.2026 · 29 (3)
DOI: 10.1007/s10456-026-10065-5 ↗Kurz gefasst
Leserbrief in der Zeitschrift Angiogenesis, online erschienen am 15.06.2026. Verfasst von M Vijayasimha und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Allied Health Science, Chandigarh University, Mohali, Punjab, 140413, India. vijaya.e19133@cumail.in. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- University Institute of Allied Health Science, Chandigarh University, Mohali, Punjab, 140413, India. vijaya.e19133@cumail.in.
- Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Medical Rd, Rohtak, Haryana, 124001, India.
- University Institute of Allied Health Science, Chandigarh University, Mohali, Punjab, 140413, India.
ORCID-Profile: M Srikanth
Zitieren
APA
Vijayasimha, M., Srikanth, M., & Rao, K. (2026). From endothelial epigenetic switching to a vascular-readiness compass for cancer immunotherapy. Angiogenesis, 29(3). https://doi.org/10.1007/s10456-026-10065-5
Vancouver
Vijayasimha M, Srikanth M, Rao K. From endothelial epigenetic switching to a vascular-readiness compass for cancer immunotherapy. Angiogenesis. 2026;29(3). doi:10.1007/s10456-026-10065-5
BibTeX
@article{Vijayasimha2026,
author = {Vijayasimha, M and Srikanth, M and Rao, Keerthi},
title = {From endothelial epigenetic switching to a vascular-readiness compass for cancer immunotherapy},
journal = {Angiogenesis},
year = {2026},
volume = {29},
number = {3},
doi = {10.1007/s10456-026-10065-5}
}
EUVIMED